Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes

• Published in: Virology journal 2016-09, Vol.13 (1), p.155-155, Article 155
• Main Authors: Jia, Junting, Ma, Yuyuan, Zhao, Xiong, Huangfu, Chaoji, Zhong, Yadi, Fang, Chi, Fan, Rui, Lv, Maomin, Zhang, Jingang
• Format: Article
• Language: English
• Subjects: Asian Continental Ancestry Group; China - epidemiology; Cluster Analysis; DNA, Viral - chemistry; DNA, Viral - genetics; Genetic aspects; Genetic Variation; Genotype; Humans; Parvoviridae Infections - epidemiology; Parvoviridae Infections - virology; Parvovirus B19, Human - classification; Parvovirus B19, Human - genetics; Parvovirus B19, Human - isolation & purification; Parvoviruses; Phylogeny; Physiological aspects; Plasma - virology; Polymerase Chain Reaction; Recombination, Genetic; Sequence Analysis, DNA
• ISSN: 1743-422X; 1743-422X
• DOI: 10.1186/s12985-016-0611-6

Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. Three distinct genotypes of B19V have been identified. The distribution of the three B19V genotypes has been investigated in various regions or countries. However, in China, data on the existence of different B19V genotypes are limited. One hundred and eighteen B19V-DNA positive source plasma pool samples collected from three Chinese blood products manufacturers were analyzed. The subgenomic NS1/VP1u region junction of B19V was amplified by nested PCR. These amplified products were then cloned and subsequently sequenced. For genotyping, their phylogenetic inferences were constructed based on the NS1/VP1-unique region. Then putative recombination events were analyzed and identified. Phylogenetic analysis of 118 B19V sequences attributed 61.86 % to genotype 1a, 10.17 % to genotype 1b, and 17.80 % to genotype 3b. All the genotype 3b sequences obtained in this study grouped as a specific, closely related cluster with B19V strain D91.1. Four 1a/3b recombinants and 5 new atypical B19V variants with no recombination events were identified. There were at least 3 subtypes (1a, 1b and 3b) of B19V circulating in China. Furthermore, putative B19V 1a/3b recombinants and unclassified strains were identified as well. Such recombinant and unclassified strains may contribute to the genetic diversity of B19V and consequently complicate the B19V infection diagnosis and NAT screening. Further studies will be required to elucidate the biological significance of the recombinant and unclassified strains.